Correlation Between NewAmsterdam Pharma and Homology Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Homology Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Homology Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Homology Medicines, you can compare the effects of market volatilities on NewAmsterdam Pharma and Homology Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Homology Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Homology Medicines.

Diversification Opportunities for NewAmsterdam Pharma and Homology Medicines

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between NewAmsterdam and Homology is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Homology Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Homology Medicines and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Homology Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Homology Medicines has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Homology Medicines go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Homology Medicines

If you would invest  890.00  in NewAmsterdam Pharma on August 31, 2024 and sell it today you would earn a total of  79.00  from holding NewAmsterdam Pharma or generate 8.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy4.55%
ValuesDaily Returns

NewAmsterdam Pharma  vs.  Homology Medicines

 Performance 
       Timeline  
NewAmsterdam Pharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, NewAmsterdam Pharma showed solid returns over the last few months and may actually be approaching a breakup point.
Homology Medicines 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Homology Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Homology Medicines is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

NewAmsterdam Pharma and Homology Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NewAmsterdam Pharma and Homology Medicines

The main advantage of trading using opposite NewAmsterdam Pharma and Homology Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Homology Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Homology Medicines will offset losses from the drop in Homology Medicines' long position.
The idea behind NewAmsterdam Pharma and Homology Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope